Mefitel film for radiation dermatitis: it works, why not?

Amivantamab Tied to Diverse Dermatologic Events in NSCLC

Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Inside Idiopathic Inflammatory Myopathies (IIMs): From Pathophysiology to Presentation

Inside Idiopathic Inflammatory Myopathies (IIMs): From Pathophysiology to Presentation

From Clinical Suspicion to Classification of Idiopathic Inflammatory Myopathies (IIMs): Biomarkers and Diagnostic Best Practices

From Clinical Suspicion to Classification of Idiopathic Inflammatory Myopathies (IIMs): Biomarkers and Diagnostic Best Practices

From Unmet Needs to Targeted Intervention: Evolving Treatment Strategies in Idiopathic Inflammatory Myopathies (IIMs)

From Unmet Needs to Targeted Intervention: Evolving Treatment Strategies in Idiopathic Inflammatory Myopathies (IIMs)

AAD: American Academy of Dermatology

Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma

Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma

Dissolving Drug for Hereditary Angioedema Helps Young Kids

Rapid symptom relief and "excellent" safety reported in small phase III trial

EADV: European Academy of Dermatology and Venereology

Hereditary Angioedema Pipeline Holding Up Long-Term

Phase II and III trial patients followed over 1 to 4 years show safety, efficacy

Regulatory T-Cell Drug Promising for Eczema, With Hint for Asthma as Well

Treg proliferator passes phase IIb hurdle in atopic dermatitis

Make the Diagnosis: This Eruption Is Spreading. Is It Related to Her Recent Organ Transplant?

A 65-year-old woman visited the doctor for a painful, crusting eruption that appeared on her face 3 days prior and was spreading. Can you diagnose the patient?

Seladelpar Eases PBC-Related Itch for 30 Months

Majority of patients achieve meaningful pruritus relief, according to long-term ASSURE data